MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is a paper indexed in ScholarIQ from OpenAlex.
How many citations does MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF have?
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF has 56 citations in the OpenAlex counts ScholarIQ stores.
When was MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF published?
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF has 2019 year in the ScholarIQ index.
What is the open-access status of MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?
MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF has gold oa status in the ScholarIQ index.
What is the DOI of MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?
The DOI for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is on the source record.
What is the PMID of MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?
The PMID for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is on the source record.
What is the OpenAlex record for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF?
The OpenAlex for MiR-30a-5p frequently downregulated in prostate cancer inhibits cell proliferation via targeting PCLAF is on the source record.